Top Buy
Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €4.78 | €12.80 | 167.814% |
Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
Masimo Corp. | 7 | 1 | 2 | 0 | €113.00 | €147.62 | 30.634% |
Molina Healthcare | 12 | 1 | 1 | 0 | €329.30 | €366.73 | 11.366% |
US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €96.00 | €109.94 | 14.525% |
Biogen Inc. | 45 | 1 | 5 | 1 | €205.70 | €294.01 | 42.932% |
AnaptysBio Inc | 9 | 1 | 4 | 0 | €24.00 | €45.21 | 88.375% |
Staar Surgical Co. | 12 | 1 | 1 | 0 | €39.91 | €49.33 | 23.596% |
Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €476.05 | €543.72 | 14.215% |
G1 Therapeutics | 15 | 1 | 3 | 0 | €4.44 | €10.56 | 137.922% |
Addus Homecare Corp. | 15 | 1 | 4 | 1 | €98.00 | €103.07 | 5.174% |
Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
Cryolife Inc. | 1 | 1 | 0 | 0 | €21.85 | €10.00 | -54.233% |
Natural Alternat. | 17 | 1 | 0 | 0 | €5.95 | - | - |
Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
Insmed Inc. | 14 | 1 | 2 | 0 | €24.00 | €43.04 | 79.343% |
Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.63 | €3.70 | 126.994% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
Atossa Genetics Inc | 5 | 1 | 1 | 0 | €1.37 | €3.72 | 171.813% |
Celldex Therapeutics | 10 | 1 | 1 | 0 | €38.40 | €51.25 | 33.453% |
Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.20 | €10.00 | 61.290% |